_version_ 1785090672377724928
author Lam Ngai, Lok
Hanekamp, Diana
Kelder, Angèle
Scholten, Willemijn J.
Carbaat - Ham, Jannemieke
Snel, Alexander N.
Bachas, Costa
Tettero, Jesse
van der Velden, Vincent
Slomp, Jennichjen
Hobo, Willemijn
Breems, Dimitri
Fischer, Thomas
Tore Gjertsen, Bjorn
Griškevičius, Laimonas
Juliusson, Gunnar
Maertens, Johan
Manz, Markus
Pabst, Thomas
Passweg, Jakob
Porkka, Kimmo
Valk, Peter
Gradowska, Patrycja
Löwenberg, Bob
de Leeuw, David
van de Loosdrecht, Arjan
Ossenkoppele, Gert
Cloos, Jacqueline
author_facet Lam Ngai, Lok
Hanekamp, Diana
Kelder, Angèle
Scholten, Willemijn J.
Carbaat - Ham, Jannemieke
Snel, Alexander N.
Bachas, Costa
Tettero, Jesse
van der Velden, Vincent
Slomp, Jennichjen
Hobo, Willemijn
Breems, Dimitri
Fischer, Thomas
Tore Gjertsen, Bjorn
Griškevičius, Laimonas
Juliusson, Gunnar
Maertens, Johan
Manz, Markus
Pabst, Thomas
Passweg, Jakob
Porkka, Kimmo
Valk, Peter
Gradowska, Patrycja
Löwenberg, Bob
de Leeuw, David
van de Loosdrecht, Arjan
Ossenkoppele, Gert
Cloos, Jacqueline
author_sort Lam Ngai, Lok
collection PubMed
description
format Online
Article
Text
id pubmed-10429281
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104292812023-08-17 P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY. Lam Ngai, Lok Hanekamp, Diana Kelder, Angèle Scholten, Willemijn J. Carbaat - Ham, Jannemieke Snel, Alexander N. Bachas, Costa Tettero, Jesse van der Velden, Vincent Slomp, Jennichjen Hobo, Willemijn Breems, Dimitri Fischer, Thomas Tore Gjertsen, Bjorn Griškevičius, Laimonas Juliusson, Gunnar Maertens, Johan Manz, Markus Pabst, Thomas Passweg, Jakob Porkka, Kimmo Valk, Peter Gradowska, Patrycja Löwenberg, Bob de Leeuw, David van de Loosdrecht, Arjan Ossenkoppele, Gert Cloos, Jacqueline Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429281/ http://dx.doi.org/10.1097/01.HS9.0000968808.37084.f7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Lam Ngai, Lok
Hanekamp, Diana
Kelder, Angèle
Scholten, Willemijn J.
Carbaat - Ham, Jannemieke
Snel, Alexander N.
Bachas, Costa
Tettero, Jesse
van der Velden, Vincent
Slomp, Jennichjen
Hobo, Willemijn
Breems, Dimitri
Fischer, Thomas
Tore Gjertsen, Bjorn
Griškevičius, Laimonas
Juliusson, Gunnar
Maertens, Johan
Manz, Markus
Pabst, Thomas
Passweg, Jakob
Porkka, Kimmo
Valk, Peter
Gradowska, Patrycja
Löwenberg, Bob
de Leeuw, David
van de Loosdrecht, Arjan
Ossenkoppele, Gert
Cloos, Jacqueline
P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
title P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
title_full P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
title_fullStr P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
title_full_unstemmed P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
title_short P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
title_sort p475: emerging leukemia associated immunophenotypes (laips) in bone marrow of acute myeloid leukemia patients after intensive chemotherapy.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429281/
http://dx.doi.org/10.1097/01.HS9.0000968808.37084.f7
work_keys_str_mv AT lamngailok p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT hanekampdiana p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT kelderangele p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT scholtenwillemijnj p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT carbaathamjannemieke p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT snelalexandern p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT bachascosta p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT tetterojesse p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT vanderveldenvincent p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT slompjennichjen p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT hobowillemijn p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT breemsdimitri p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT fischerthomas p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT toregjertsenbjorn p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT griskeviciuslaimonas p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT juliussongunnar p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT maertensjohan p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT manzmarkus p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT pabstthomas p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT passwegjakob p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT porkkakimmo p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT valkpeter p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT gradowskapatrycja p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT lowenbergbob p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT deleeuwdavid p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT vandeloosdrechtarjan p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT ossenkoppelegert p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy
AT cloosjacqueline p475emergingleukemiaassociatedimmunophenotypeslaipsinbonemarrowofacutemyeloidleukemiapatientsafterintensivechemotherapy